Support for new S3 listing

pharmacist prescribing
Pharmacy Guild and other groups voice support for a new Schedule 3 listing for celecoxib The Pharmacy Guild of Australia and other peak health stakeholder groups have supported a decision to create a new Schedule 3 category for the NSAID celecoxib. The March 2023 meeting of the Therapeutic Goods Administration's Advisory Committee on Medicines Scheduling

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Overcoming the language barrier
Next The search for security